Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

PR Newswire
July 20, 2020 — 08:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Beijing China Dollar Employee Export Exports Fidelity finance guangdong healthcare Hillhouse Capital Group Hong Kong internet investment JD finance manufacturing medicine Meituan Dianping Pacific pharmaceutical Private Equity Qiming Venture Partners real estate Renminbi retail Seattle Shanghai shenzhen singapore software stock exchange stock market Suzhou technology Ubtech venture capital Xiaomi Zoom

Related News:

AVAPOW’s Black Friday Event: Essential Automotive Tools At Exclusive Prices

November 22, 2024 — 04:00

Crystal clear: Pingcheng period glassware of Northern Wei Dynasty

November 9, 2024 — 08:00

Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

November 8, 2024 — 17:45

New features revealed for PaperCut Hive cloud print management solution

November 8, 2024 — 06:32

LPS Launches NeuroNode: Empowering Advanced AI for Enterprises with On-Premises LLM

November 7, 2024 — 17:39

Cybellum Receives Frost & Sullivan’s Competitive Strategy Award for its Innovative Product Security Solutions

September 27, 2024 — 01:00

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

September 14, 2024 — 08:18

Desay Battery Highlights Advanced Energy Solutions at RE+ 2024

September 11, 2024 — 03:00

Announcement of ICAIRE’s Classification as a UNESCO Category 2 Center at the Global AI Summit

September 11, 2024 — 02:34

Franchising and Licensing Asia (FLAsia) 2024